ArticleVaccines2026

A Randomized, Double-Blind, Placebo-Controlled Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an Outer Membrane Vesicle (OMV) Platform-Based Vaccine Administered Intranasally to Healthy Adults.

Heleen Kraan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.